Cardiovascular disease incidence rates: a study using routinely collected health data

Cardio-Oncology

Table 3 30-year cumulative risks (%) of developing incident CVD for example early-stage Hodgkin lymphoma patients, by sex, age at treatment, and type of treatment

Age at treatment (years)	30-year cumulative risks of incident CVD (%)
	MALES			FEMALES
	Treatment Type			Treatment Type
	None	CT Only	CT & RT	None	CT Only	CT & RT
20	4.6	7.3	12.4	3.7	6.4	10.0
30	10.9	16.3	23.6	7.1	11.6	16.1
40	20.6	31.3	38.4	13.6	22.1	26.6
50	31.7	49.9	57.6	24.8	41.3	46.8
60	35.9	59.3	67.5	32.9	56.8	64.0

CT Chemotherapy (in this case three cycles of ABVD, including 150 mg/m² of anthracyclines), CT & RT Chemotherapy and radiotherapy
CVD rates were obtained using Method A1 and are shown in Fig. 3 and Table e2. Competing risks of death from causes other than CVD were assumed to be equal to those in the general population and were taken into account. Further details are given in Additional Text e1

ISSN: 2057-3804